Video

Session 7 : ER+Ve Breast Cancer

Debate

Chairpersons :

P P Bapsy, Shailesh Talati

Fulvestrant is the appropriate 1st line option for low volume metatstatic Er+Ve disease -Chanchal Goswami

VS

Letrozole + Palbociclib is the appropriate 1st line option for low volume metatstatic Er+Ve disease - Chirag Desai